OUTCOMES OF ALLOGENEIC SC TRANSPLANT IN HEMATOLOGICAL MALIGNANCY PATIENTS USING BUSULFAN 3 (9.6 MG/KG) BASED CONDITIONING REGIMEN

Objective: To study the outcomes of allo-HCT in patients with hematological malignancy who received BU3 (9.6 mg/kg) based conditioning from matched related or unrelated donors. Methodology: A retrospective analysis of KFSHRC- BMT Database, we identified 65 patients who received Allo-HCT between Octo...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Majed Altareb, Yazeed Bajuaifer, Walid Rasheed
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
Accès en ligne:https://doaj.org/article/990786919fe843c4b5cddd2870568c6b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!